Vaccine Adjuvants Market Trends, Growth Analysis, Investigation by Regions, Types, Applications and Analysis of Key Players

The QY Research released a latest market research report on the Global Vaccine Adjuvants market, which is segmented by region (country), company and by Application. Players, stakeholders, and other participants in the global Vaccine Adjuvants market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country) and by Application of Global Vaccine Adjuvants market.

For More Information About This Report, Please Enter:

https://us.qyresearch.com/reports/348668/vaccine-adjuvants

Summary

Market Analysis and Insights: Global Vaccine Adjuvants Market

The global Vaccine Adjuvants market is valued at US$ 650 million in 2020. The market size will reach US$ 1428 million by the end of 2027, growing at a CAGR of 8.97% during 2021-2027.

The report mentions the prominent market player consisting of:

GSK

CSL Limited

Croda

SEPPIC

Novavax

SPI Pharma

Phibro

SDA BIO

Invivogen

Tj Kaiwei

OZ Biosciences

Vaccine Adjuvants Market Segment by Type

Aluminum Adjuvant

Emulsions Adjuvant

Other

Vaccine Adjuvants Market Segment by Application

Human Vaccine

Veterinary Vaccine

The report on the Vaccine Adjuvants market covers the following region (country) analysis:

North America

United States

Canada

Mexico

Asia-Pacific

China

Japan

South Korea

India

Southeast Asia

Australia

Other Regions

Europe

Germany

U.K.

France

Italy

Russia

Rest of Europe

South America

Brazil

Rest of South America

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

Other Regions

 

The Goal of the Report

To study and analyze the global Vaccine Adjuvantsconsumption (value & volume) by key regions/countries, type and application, history data from 2017 to 2022, and forecast to 2028.
To understand the structure of Vaccine Adjuvantsmarket by identifying its various subsegments.
Focuses on the key global Vaccine Adjuvantsmanufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Vaccine Adjuvantswith respect to individual growth trends, prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges, and risks).
To project the consumption of Vaccine Adjuvantssubmarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Target Audience

> Vaccine Adjuvants companies

> Research organizations

> Government Organizations

> Research/Consultancy firms

Table of Contents

 

1 STUDY COVERAGE 1
1.1 Vaccine Adjuvants Product Introduction 1
1.2 Market by Type 1
1.2.1 Global Vaccine Adjuvants Market Size Growth Rate by Type 1
1.2.2 Aluminum Adjuvant 3
1.2.3 Emulsions Adjuvant 4
1.3 Market by Application 4
1.3.1 Global Vaccine Adjuvants Market Size Growth Rate by Application 4
1.3.2 Human Vaccine 5
1.3.3 Veterinary Vaccine 6
1.4 Study Objectives 7
1.5 Years Considered 8

2 EXECUTIVE SUMMARY 9
2.1 Global Vaccine Adjuvants Sales Estimates and Forecasts 2016-2027 9
2.2 Global Vaccine Adjuvants Revenue Estimates and Forecasts 2016-2027 10
2.3 Global Vaccine Adjuvants Revenue by Region: 2016 VS 2021 VS 2027 11
2.4 Global Top Vaccine Adjuvants Regions by Sales 13
2.4.1 Global Top Vaccine Adjuvants Regions by Sales (2016-2021) 13
2.4.2 Global Top Vaccine Adjuvants Regions by Sales (2022-2027) 14
2.5 Global Top Vaccine Adjuvants Regions by Revenue 15
2.5.1 Global Top Vaccine Adjuvants Regions by Revenue (2016-2021) 15
2.5.2 Global Top Vaccine Adjuvants Regions by Revenue (2022-2027) 16
2.6 North America 17
2.7 Europe 18
2.8 Asia-Pacific 19
2.9 South America 20
2.10 Middle East & Africa 21

3 COMPETITION BY MANUFACTURERS 22
3.1 Global Vaccine Adjuvants Sales by Manufacturers 22
3.1.1 Global Top Vaccine Adjuvants Manufacturers by Sales (2019-2021) 22
3.1.2 Global Top Vaccine Adjuvants Manufacturers Market Share by Sales (2019-2021) 23
3.1.3 Global Top Companies by Vaccine Adjuvants Sales in 2020 24
3.2 Global Vaccine Adjuvants Revenue by Manufacturers 24
3.2.1 Global Top Vaccine Adjuvants Manufacturers by Revenue (2019-2021) 24
3.2.2 Global Top Vaccine Adjuvants Manufacturers Market Share by Revenue (2019-2021) 25
3.2.3 Global Top Companies by Vaccine Adjuvants Revenue in 2020 26
3.3 Global Vaccine Adjuvants Sales Price by Manufacturers 26
3.4 Analysis of Competitive Landscape 27
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 27
3.4.2 Global Vaccine Adjuvants by Company Type (Tier 1, Tier 2, and Tier 3) 28
3.4.3 Global Vaccine Adjuvants Manufacturers Geographical Distribution 28
3.5 Mergers & Acquisitions, Expansion Plans 30

4 MARKET SIZE BY TYPE 33
4.1 Global Vaccine Adjuvants Sales by Type 33
4.1.1 Global Vaccine Adjuvants Historical Sales by Type (2016-2021) 33
4.1.2 Global Vaccine Adjuvants Forecasted Sales by Type (2022-2027) 33
4.1.3 Global Vaccine Adjuvants Sales Market Share by Type (2016-2027) 33
4.2 Global Vaccine Adjuvants Revenue by Type 34
4.2.1 Global Vaccine Adjuvants Historical Revenue by Type (2016-2021) 34
4.2.2 Global Vaccine Adjuvants Forecasted Revenue by Type (2022-2027) 35
4.2.3 Global Vaccine Adjuvants Revenue Market Share by Type (2016-2027) 35
4.3 Global Vaccine Adjuvants Price by Type 36
4.3.1 Global Vaccine Adjuvants Price by Type (2016-2021) 36
4.3.2 Global Vaccine Adjuvants Price Forecast by Type (2022-2027) 36

5 MARKET SIZE BY APPLICATION 37
5.1 Global Vaccine Adjuvants Sales by Application 37
5.1.1 Global Vaccine Adjuvants Historical Sales by Application (2016-2021) 37
5.1.2 Global Vaccine Adjuvants Forecasted Sales by Application (2022-2027) 37
5.1.3 Global Vaccine Adjuvants Sales Market Share by Application (2016-2027) 37
5.2 Global Vaccine Adjuvants Revenue by Application 38
5.2.1 Global Vaccine Adjuvants Historical Revenue by Application (2016-2021) 38
5.2.2 Global Vaccine Adjuvants Forecasted Revenue by Application (2022-2027) 38
5.2.3 Global Vaccine Adjuvants Revenue Market Share by Application (2016-2027) 39
5.3 Global Vaccine Adjuvants Price by Application 40
5.3.1 Global Vaccine Adjuvants Price by Application (2016-2021) 40
5.3.2 Global Vaccine Adjuvants Price Forecast by Application (2022-2027) 40

6 NORTH AMERICA 41
6.1 North America Vaccine Adjuvants Market Size by Type 41
6.1.1 North America Vaccine Adjuvants Sales by Type (2016-2027) 41
6.1.2 North America Vaccine Adjuvants Revenue by Type (2016-2027) 42
6.2 North America Vaccine Adjuvants Market Size by Application 43
6.3 North America Vaccine Adjuvants Market Size by Country 44
6.3.1 North America Vaccine Adjuvants Sales by Country (2016-2027) 44
6.3.2 North America Vaccine Adjuvants Revenue by Country (2016-2027) 45
6.3.3 United States 46
6.3.4 Canada 46
6.3.5 Mexico 47

7 EUROPE 48
7.1 Europe Vaccine Adjuvants Market Size by Type 48
7.1.1 Europe Vaccine Adjuvants Sales by Type (2016-2027) 48
7.1.2 Europe Vaccine Adjuvants Revenue by Type (2016-2027) 49
7.2 Europe Vaccine Adjuvants Market Size by Application 50
7.3 Europe Vaccine Adjuvants Market Size by Country 51
7.3.1 Europe Vaccine Adjuvants Sales by Country (2016-2027) 51
7.3.2 Europe Vaccine Adjuvants Revenue by Country (2016-2027) 52
7.3.3 Germany 53
7.3.4 U.K. 54
7.3.5 France 54
7.3.6 Italy 55
7.3.7 Russia 55

8 ASIA PACIFIC 56
8.1 Asia Pacific Vaccine Adjuvants Market Size by Type 56
8.1.1 Asia Pacific Vaccine Adjuvants Sales by Type (2016-2027) 56
8.1.2 Asia Pacific Vaccine Adjuvants Revenue by Type (2016-2027) 57
8.2 Asia Pacific Vaccine Adjuvants Market Size by Application 58
8.3 Asia Pacific Vaccine Adjuvants Market Size by Region 59
8.3.1 Asia Pacific Vaccine Adjuvants Sales by Region (2016-2027) 59
8.3.2 Asia Pacific Vaccine Adjuvants Revenue by Region (2016-2027) 60
8.3.3 China 61
8.3.4 Japan 62
8.3.5 South Korea 62
8.3.6 India 63
8.3.7 Southeast Asia 63
8.3.8 Australia 64

9 SOUTH AMERICA 65
9.1 South America Vaccine Adjuvants Market Size by Type 65
9.1.1 South America Vaccine Adjuvants Sales by Type (2016-2027) 65
9.1.2 South America Vaccine Adjuvants Revenue by Type (2016-2027) 65
9.2 South America Vaccine Adjuvants Market Size by Application 66
9.3 South America Vaccine Adjuvants Market Size by Country 66
9.3.1 South America Vaccine Adjuvants Sales by Country (2016-2027) 66
9.3.2 South America Vaccine Adjuvants Revenue by Country (2016-2027) 67
9.3.3 Brazil 68

10 MIDDLE EAST AND AFRICA 69
10.1 Middle East and Africa Vaccine Adjuvants Market Size by Type 69
10.1.1 Middle East and Africa Vaccine Adjuvants Sales by Type (2016-2027) 69
10.1.2 Middle East and Africa Vaccine Adjuvants Revenue by Type (2016-2027) 69
10.2 Middle East and Africa Vaccine Adjuvants Market Size by Application 70
10.3 Middle East and Africa Vaccine Adjuvants Market Size by Country 71
10.3.1 Middle East and Africa Vaccine Adjuvants Sales by Country (2016-2027) 71
10.3.2 Middle East and Africa Vaccine Adjuvants Revenue by Country (2016-2027) 72
10.3.3 Turkey 73
10.3.4 Saudi Arabia 74
10.3.5 U.A.E 74

11 CORPORATE PROFILE 75
11.1 GSK 75
11.1.1 GSK Corporation Information 75
11.1.2 GSK Overview 75
11.1.3 GSK Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2021) 76
11.1.4 GSK Vaccine Adjuvants Product Description 76
11.1.5 GSK Recent Developments 77
11.2 CSL Limited 77
11.2.1 CSL Limited Corporation Information 77
11.2.2 CSL Limited Overview 78
11.2.3 CSL Limited Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2021) 78
11.2.4 CSL Limited Vaccine Adjuvants Product Description 78
11.2.5 CSL Limited Recent Developments 79
11.3 Croda 79
11.3.1 Croda Corporation Information 79
11.3.2 Croda Overview 80
11.3.3 Croda Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2021) 80
11.3.4 Croda Vaccine Adjuvants Product Description 81
11.3.5 Croda Recent Developments 81
11.4 SEPPIC 82
11.4.1 SEPPIC Corporation Information 82
11.4.2 SEPPIC Overview 83
11.4.3 SEPPIC Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2021) 83
11.4.4 SEPPIC Vaccine Adjuvants Product Description 83
11.5 Novavax 84
11.5.1 Novavax Corporation Information 84
11.5.2 Novavax Overview 85
11.5.3 Novavax Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2021) 85
11.5.4 Novavax Vaccine Adjuvants Product Description 85
11.6 SPI Pharma 86
11.6.1 SPI Pharma Corporation Information 86
11.6.2 SPI Pharma Overview 86
11.6.3 SPI Pharma Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2021) 87
11.6.4 SPI Pharma Vaccine Adjuvants Product Description 87
11.7 Phibro 88
11.7.1 Phibro Corporation Information 88
11.7.2 Phibro Overview 88
11.7.3 Phibro Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2021) 89
11.7.4 Phibro Vaccine Adjuvants Product Description 89
11.7.5 Phibro Recent Developments 90
11.8 SDA BIO 90
11.8.1 SDA BIO Corporation Information 90
11.8.2 SDA BIO Overview 91
11.8.3 SDA BIO Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2021) 91
11.8.4 SDA BIO Vaccine Adjuvants Product Description 91
11.9 Invivogen 92
11.9.1 Invivogen Corporation Information 92
11.9.2 Invivogen Overview 92
11.9.3 Invivogen Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2021) 93
11.9.4 Invivogen Vaccine Adjuvants Product Description 93
11.10 Tj Kaiwei 94
11.10.1 Tj Kaiwei Corporation Information 94
11.10.2 Tj Kaiwei Overview 94
11.10.3 Tj Kaiwei Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2021) 95
11.10.4 Tj Kaiwei Vaccine Adjuvants Product Description 95
11.11 OZ Biosciences 96
11.11.1 OZ Biosciences Corporation Information 96
11.11.2 OZ Biosciences Overview 96
11.11.3 OZ Biosciences Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2021) 97
11.11.4 OZ Biosciences Vaccine Adjuvants Product Description 97

12 VALUE CHAIN AND SALES CHANNELS ANALYSIS 99
12.1 Vaccine Adjuvants Value Chain Analysis 99
12.2 Vaccine Adjuvants Key Raw Materials 100
12.2.1 Key Raw Materials 100
12.2.2 Raw Materials Key Suppliers 100
12.3 Vaccine Adjuvants Production Mode & Process 101
12.4 Vaccine Adjuvants Sales and Marketing 101
12.4.1 Vaccine Adjuvants Sales Channels 101
12.4.2 Vaccine Adjuvants Distributors 103
12.5 Vaccine Adjuvants Customers 104

13 MARKET DRIVERS, OPPORTUNITIES, CHALLENGES AND RISKS FACTORS ANALYSIS 106
13.1 Vaccine Adjuvants Industry Trends 106
13.2 Vaccine Adjuvants Market Drivers 107
13.3 Vaccine Adjuvants Market Challenges 107
13.4 Vaccine Adjuvants Market Restraints 108

14 KEY FINDINGS IN THE GLOBAL VACCINE ADJUVANTS STUDY 109

15 APPENDIX 111
15.1 Research Methodology 111
15.1.1 Methodology/Research Approach 111
15.1.2 Data Source 114
15.2 Author Details 117
15.3 Disclaimer 117

Access full Report Description, Table of Figure, Chart, FREE sample, etc. please click 

https://us.qyresearch.com/reports/348668/vaccine-adjuvants

Any doubts and questions will be welcome.

Customization of the Report:

This report can be customized to meet the client's requirements. Please contact with us (global@qyresearch.com), who will ensure that you get a report that suits your needs.

About Us:

QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 15 years' experience and professional research team in various cities over the world，QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let's work closely with you and build a bold and better future.

Contact Us

QY Research

E-mail: global@qyresearch.com

Tel: +1-626-842-1666(US)   +852-5808-0956 (HK)

Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States

Website: https://us.qyresearch.com

The QY Research released a latest market research report on the Global Vaccine Adjuvants market, which is segmented by region (country), company and by Application. Players, stakeholders, and other participants in the global Vaccine Adjuvants market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country) and by Application of Global Vaccine Adjuvants market.

QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 15 years' experience and professional research team in various cities over the world，QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let's work closely with you and build a bold and better future.

This release was published on openPR.